Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar 4;16(3):4880-903.
doi: 10.3390/ijms16034880.

Silk fibroin-based nanoparticles for drug delivery

Affiliations
Review

Silk fibroin-based nanoparticles for drug delivery

Zheng Zhao et al. Int J Mol Sci. .

Abstract

Silk fibroin (SF) is a protein-based biomacromolecule with excellent biocompatibility, biodegradability and low immunogenicity. The development of SF-based nanoparticles for drug delivery have received considerable attention due to high binding capacity for various drugs, controlled drug release properties and mild preparation conditions. By adjusting the particle size, the chemical structure and properties, the modified or recombinant SF-based nanoparticles can be designed to improve the therapeutic efficiency of drugs encapsulated into these nanoparticles. Therefore, they can be used to deliver small molecule drugs (e.g., anti-cancer drugs), protein and growth factor drugs, gene drugs, etc. This paper reviews recent progress on SF-based nanoparticles, including chemical structure, properties, and preparation methods. In addition, the applications of SF-based nanoparticles as carriers for therapeutic drugs are also reviewed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram of the desolvation method for preparing silk fibroin (SF) nanoparticles.
Figure 2
Figure 2
Schematic diagram of the salting out method for preparing SF nanoparticles.
Figure 3
Figure 3
Schematic diagram of the SEDS process for preparing SF nanoparticles. Adapted with permission from [34]. Copyright 2013 American Chemical Society.
Figure 4
Figure 4
Schematic diagram of the electrospraying method for preparing SF nanoparticles.
Figure 5
Figure 5
Schematic diagram of the mechanical comminution method for preparing particles.
Figure 6
Figure 6
Schematic diagram of the microemulsion method for preparing SF nanoparticles. Adapted with permission from [41]. Copyright 2008 Springer.
Figure 7
Figure 7
Schematic diagram of the electric fields method for preparing SF nanoparticles.
Figure 8
Figure 8
Schematic diagram of the capillary-microdot technique for preparing SF nanoparticles.
Figure 9
Figure 9
Schematic diagram of the PVA blend film method for preparing SF nanoparticles.

Similar articles

Cited by

References

    1. Kreuter J. Nanoparticles as drug delivery systems. Encycl. Nanosci. Nanotechnol. 2004;7:161–180.
    1. Birrenbach G., Speiser P.P. Polymerized micelles and their use as adjuvants in immunology. J. Pharm. Sci. 1976;65:1763–1766. doi: 10.1002/jps.2600651217. - DOI - PubMed
    1. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 2008;5:505–515. - PMC - PubMed
    1. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B. 2010;75:1–18. doi: 10.1016/j.colsurfb.2009.09.001. - DOI - PubMed
    1. Elzoghby A.O., Samy W.M., Elgindy N.A. Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Control. Release. 2012;157:168–182. doi: 10.1016/j.jconrel.2011.07.031. - DOI - PubMed

Publication types

MeSH terms